• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[顽固性腹水手术后的长期随访]

[Long-term follow up after surgery for intractable ascites].

作者信息

Bancu L, Bara T, Jimboreanu O, Mureşan M, Bancu S

机构信息

Clinica Medical nr. 2. Spitalul Universitar Judeţean de Urgenţä Tg. Mureş.

出版信息

Chirurgia (Bucur). 2009 Nov-Dec;104(6):719-21.

PMID:20187471
Abstract

UNLABELLED

The aim of the study is to evaluate the outcome of a selected group of 24 patients who underwent surgery for refractory ascites, in a 10 years period, 1995-2005.

CLINICAL DIAGNOSIS

Alcoholic cirrhosis (n=18), inferior cava thrombosis (n=2), splenic vein thrombosis (n=1), cryptogenic cirrhosis (n=3), with association of variceal bleeding and refractory ascites. The surgical procedures consisted of porto-sistemic shunts (n=12), peritoneo-saphene shunts (n=10), mesenterico-caval shunt (n=1), mesenterico-right atrium shunt (n=1). Early results were very good: no postoperative mortality, no general haemo-dinamic failure, no renal fonctional failure, no encephalopathy. 7 of 10 peritoneo-saphene shunts had an excelent evolution, but in three cases the results were unsatisfactory, the patients continuing the medical treatment. Except one patient who died after 2 years, for B virus and alcoholic abuse, all the patients survived 5 or more years. There was not evidence of digestive hemorrhage or uncontrolable encephalopathy and thrombocytopenia. The grade of esophageal varices was mantained lower than II, ascites remained minimum or absent, and biological parameters were normal or slightly elevated.

CONCLUSIONS

In the absence of the technical and economical possibilities of TIPS and liver transplantation, surgery for intractable ascites is a good option in selected patients, especially in the absence of viruses and alcohol consumption, and can improve complications in the natural evolution of the disease.

摘要

未标注

本研究旨在评估1995年至2005年期间接受难治性腹水手术的24例特定患者的治疗结果。

临床诊断

酒精性肝硬化(n = 18)、下腔静脉血栓形成(n = 2)、脾静脉血栓形成(n = 1)、隐源性肝硬化(n = 3),伴有静脉曲张破裂出血和难治性腹水。手术方式包括门体分流术(n = 12)、腹膜-大隐静脉分流术(n = 10)、肠系膜-腔静脉分流术(n = 1)、肠系膜-右心房分流术(n = 1)。早期结果非常好:无术后死亡、无全身血液动力学衰竭、无肾功能衰竭、无肝性脑病。10例腹膜-大隐静脉分流术中7例进展良好,但3例结果不理想,患者继续接受药物治疗。除1例因B病毒感染和酒精滥用在2年后死亡外,所有患者均存活5年或更长时间。无消化出血、无法控制的肝性脑病和血小板减少的证据。食管静脉曲张程度维持在II级以下,腹水保持最少或消失,生物学指标正常或略有升高。

结论

在没有经颈静脉肝内门体分流术(TIPS)和肝移植的技术及经济条件时,难治性腹水手术对特定患者是一个不错的选择,尤其是在没有病毒感染和饮酒的情况下,并且可以改善疾病自然发展过程中的并发症。

相似文献

1
[Long-term follow up after surgery for intractable ascites].[顽固性腹水手术后的长期随访]
Chirurgia (Bucur). 2009 Nov-Dec;104(6):719-21.
2
The use and misuse of transjugular intrahepatic portasystemic shunts.经颈静脉肝内门体分流术的应用与误用
Curr Gastroenterol Rep. 2000 Feb;2(1):61-71. doi: 10.1007/s11894-000-0053-5.
3
Transjugular intrahepatic portosystemic shunt creation with the Viatorr expanded polytetrafluoroethylene-covered stent-graft.使用Viatorr膨体聚四氟乙烯覆膜支架移植物建立经颈静脉肝内门体分流术。
J Vasc Interv Radiol. 2004 Mar;15(3):239-48. doi: 10.1097/01.rvi.0000116194.44877.c1.
4
Transjugular intrahepatic portosystemic shunt vs. small-diameter prosthetic H-graft portacaval shunt: extended follow-up of an expanded randomized prospective trial.经颈静脉肝内门体分流术与小直径人工血管H型门腔分流术:一项扩大的随机前瞻性试验的长期随访
J Gastrointest Surg. 2000 Nov-Dec;4(6):589-97. doi: 10.1016/s1091-255x(00)80107-9.
5
[Transjugular intrahepatic portacaval shunt. Preliminary results].
Gastroenterol Clin Biol. 1993;17(6-7):422-30.
6
[Experience with the transjugular intrahepatic portocaval shunt].
Ann Chir. 1994;48(8):671-8.
7
Differences in long-term survival after transjugular intrahepatic portosystemic shunt for refractory ascites and variceal bleed.经颈静脉肝内门体分流术治疗顽固性腹水和静脉曲张出血后的长期生存率差异。
J Gastroenterol Hepatol. 2005 Mar;20(3):474-81. doi: 10.1111/j.1440-1746.2005.03601.x.
8
[Transjugular intrahepatic portasystemic shunt and liver transplantation].经颈静脉肝内门体分流术与肝移植
Ann Radiol (Paris). 1994;37(5):316-22.
9
Long-term clinical outcome and survival predictors in patients with cirrhosis after 10-mm-covered transjugular intrahepatic portosystemic shunt.10mm 覆盖型经颈静脉肝内门体分流术后肝硬化患者的长期临床转归和生存预测因素。
Gastroenterol Hepatol. 2021 Nov;44(9):620-627. doi: 10.1016/j.gastrohep.2020.10.018. Epub 2020 Nov 26.
10
Long-term effects and complications of the transjugular intrahepatic portosystemic shunt: a single-centre experience.经颈静脉肝内门体分流术的长期影响及并发症:单中心经验
Scand J Gastroenterol. 2019 Jul;54(7):899-904. doi: 10.1080/00365521.2019.1630675. Epub 2019 Jun 16.